Lebenthal Global Advisors’s Nu Skin NUS Stock Holding History

Lebenthal Global Advisors’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,387	Closed	-$130K	–	397
2020 Q4	$130K	Buy	+2,387	New	+$126K	0.09%	139

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lebenthal Global Advisors's NUS Position: Q1 2021 in Review

Lebenthal Global Advisors sold out of Nu Skin (NUS) in Q1 2021, closing a stake of 2,387 shares — an estimated $130K sold.

Lebenthal Global Advisors first reported a position in NUS in Q4 2020 and held it in 1 quarter. The position peaked at $130K in Q4 2020. 276 funds tracked by Wall St. Rank hold NUS as of Q1 2021.

Lebenthal Global Advisors reported no remaining Nu Skin position as of Q1 2021 after selling out during the quarter.
Lebenthal Global Advisors sold 2,387 Nu Skin shares in Q1 2021, an estimated $130K.
Lebenthal Global Advisors first reported a position in Nu Skin in Q4 2020 and held it in 1 quarter.
Lebenthal Global Advisors's Nu Skin position peaked at $130K in Q4 2020.
276 funds tracked by Wall St. Rank held Nu Skin as of Q1 2021.

Based on Lebenthal Global Advisors's 13F filing for Q1 2021, filed 7 May 2021.